Clinical Trials Browser

Phase 3 × Has results × Spondylitis, Ankylosing × Clear all

NCT01209689 2013-01-17

A Study of Tocilizumab (RoActemra/Actemra) in Patients With Ankylosing Spondylitis Who Have Had an Inadequate Response to Previous Tumor Necrosis Factor (TNF) Antagonist Therapy

Phase 3 Terminated

113 enrolled 7 charts

Spondylitis, Ankylosing